Skip to main content
v2026.11,610 entries · CC-BY 4.0
LAC HealthLaboratory & ResearchLab & research supplies.Reagents, consumables, PPE & instruments — documented, fast, chain-of-custody shipping.Shop lac.us lac.us

Stanford v. Roche (2011): Why Bayh-Dole Doesn’t Automatically Give Universities Inventor Rights

The Supreme Court held in Stanford v. Roche (2011) that the Bayh-Dole Act does not itself vest title to federally funded inventions in a university — inventors retain rights absent a valid, present-tense assignment. This guide explains the holding and why it drove TTOs to rewrite invention-assignment agreements using “hereby assign” language.

In 2011, the U.S. Supreme Court settled a question that had been quietly assumed away by many research institutions: does the Bayh-Dole Act itself give a university title to an invention made with federal funding? In Board of Trustees of the Leland Stanford Junior University v. Roche Molecular Systems, Inc., 563 U.S. 776 (2011), the Court answered no. Bayh-Dole regulates what a university may do with title once it has it — it does not, by itself, transfer inventor ownership to the university. Title still has to be acquired the ordinary way patent law requires: through a valid assignment from the inventor. That distinction reshaped how technology transfer offices (TTOs) draft invention-assignment agreements, and it remains the legal foundation underneath the Bayh-Dole compliance and march-in-rights framework CASRAI covers elsewhere.

The case: Stanford v. Roche

The dispute began with a Stanford research fellow, Dr. Mark Holodniy, who signed two agreements years apart that turned out to conflict. When he joined Stanford, he signed the university’s standard Copyright and Patent Agreement, in which he agreed that he “will assign” to Stanford his right, title, and interest in inventions resulting from his university employment — language courts read as a promise to assign in the future, not an assignment itself. Shortly afterward, Holodniy did training at Cetus Corporation (later acquired by Roche) to learn a PCR-based technique. As a condition of that visit, he signed Cetus’s Visitor’s Confidentiality Agreement, which stated he “will assign and do hereby assign” his right, title, and interest in any inventions made as a result of the visit to Cetus.

Holodniy returned to Stanford and, working with colleagues, helped develop an improved method for quantifying HIV levels in blood using PCR — research that was funded in part by federal grants and was later patented by Stanford. When Roche began selling HIV test kits that used the technique, Stanford sued for infringement. Roche’s defense was that it already co-owned the patents, because Cetus (Roche’s predecessor) had obtained rights to Holodniy’s invention through his “hereby assign” agreement before Stanford’s rights ever vested.

The case reached the Supreme Court on the question of whether the Bayh-Dole Act overrode ordinary patent-assignment law for federally funded inventions — specifically, whether the Act automatically vested title in the university-contractor, ahead of any individual inventor’s separate assignment. Chief Justice Roberts wrote the majority opinion, joined by six other justices, affirming the Federal Circuit’s ruling for Roche; Justice Sotomayor concurred separately, and Justices Breyer and Ginsburg dissented. (Citation: 563 U.S. 776; 131 S. Ct. 2188 (2011); Docket No. 09-1159.)

What the Supreme Court actually held

The Court’s holding is narrower — and more consequential for contract drafting — than the case is often summarized as being. It did not say universities cannot own federally funded inventions, and it did not disturb Bayh-Dole’s compliance framework (invention disclosure, election of title, government march-in rights, and so on) once title is validly held by a contractor. What it held is that Bayh-Dole does not itself vest title in the contractor institution the moment a federally funded invention is made. Patent law’s long-standing default rule — that rights in an invention initially belong to the individual inventor, not the inventor’s employer or funder — still applies. A university (or any Bayh-Dole “contractor”) acquires title only by obtaining a valid, effective assignment from the inventor, the same as any other employer would. Bayh-Dole’s text, the Court noted, speaks in terms of a contractor “retain[ing] title” to inventions it already owns; it does not use the language of an automatic, self-executing transfer of ownership.

That left the case turning entirely on ordinary contract-assignment doctrine: which of Holodniy’s two agreements had actually transferred his ownership interest, and when. Stanford’s agreement used future-tense language (“will assign”), which courts had already established creates only a promise to assign at some future point — a contractual obligation enforceable between the parties, but not itself a transfer of legal title. Cetus’s agreement used present-tense language (“do hereby assign”), which effects an immediate, automatic assignment the moment the invention is conceived, with no further act required. Because Cetus’s assignment language executed automatically and Stanford’s did not, Cetus (and later Roche) obtained legal title to Holodniy’s interest first, before Stanford’s later, weaker assignment could reach it. Stanford’s federal-funding relationship and its Bayh-Dole election of title were not enough to override that sequence.

Why “agree to assign” and “do hereby assign” are not the same thing

This drafting distinction predates Stanford v. Roche — it comes out of older Federal Circuit assignment case law (notably FilmTec Corp. v. Allied-Signal, Inc.) — but the Supreme Court’s decision is what made it unavoidable for every research institution’s standard invention-assignment paperwork:

  • “I agree to assign” / “will assign” is a promise to assign rights at a future date. It creates a contractual right the university can sue to enforce, but it does not, by itself, transfer legal title to the invention when the invention comes into existence. If a third party obtains a present, automatic assignment from the same inventor before the university perfects its promised assignment, the third party can win the priority contest — exactly what happened to Stanford.
  • “I hereby assign” / “do hereby assign” is a present-tense assignment of the inventor’s interest in future inventions. Courts treat this language as operating automatically, transferring equitable and (once the invention exists) legal title the instant the invention is conceived, with no additional signature or instrument needed at that later point.

The difference sounds like drafting pedantry, but it decided ownership of a patent portfolio worth defending all the way to the Supreme Court.

Practical impact on TTO invention-assignment agreements

Following the decision, technology transfer offices and university counsel widely reviewed and, in many cases, rewrote their standard patent/invention agreements, employment offer letters, and visiting-researcher or collaboration agreements to close the gap the case exposed. Common changes include:

  • Present-tense assignment language. Replacing “agree to assign” or “will assign” with “hereby assign” (or “hereby assign and agree to assign,” to cover both existing and future inventions) in the operative clause, so the university’s own agreement executes automatically rather than merely promising a future transfer.
  • Signature at the point of hire or engagement, not just at disclosure. Making sure invention-assignment language is captured the moment an individual becomes a covered inventor — new employee, graduate student, postdoc, or visiting researcher — rather than only when a specific invention is later disclosed, since a later, better-drafted third-party agreement can otherwise get there first.
  • Coverage of visitors and collaborators, not only employees. Stanford v. Roche arose specifically because a visiting researcher signed a competing agreement with a host institution. TTOs extended present-tense assignment language to visiting scientist agreements, materials transfer and collaboration agreements, and consulting agreements for exactly this reason.
  • Confirmatory assignments as a backstop, not a substitute. Many institutions still require a separate, invention-specific confirmatory assignment at the time of disclosure. Post-Stanford v. Roche, that document is treated as evidence confirming a transfer that already happened under the standing present-tense agreement, not as the instrument that itself does the transferring — because if it is the only transfer instrument, a competing “hereby assign” from elsewhere can still arrive first.

None of this changes an institution’s underlying Bayh-Dole obligations once it validly holds title — timely invention disclosure, election of title, and the government’s retained rights described in CASRAI’s guide to 37 CFR 401 implementing regulations and Bayh-Dole march-in rights. Stanford v. Roche sits one step earlier in the chain: it is about how the university gets to “yes, we hold title” in the first place, which every downstream Bayh-Dole compliance step assumes.

Ongoing relevance for research administrators

The case remains the standard citation whenever an institution’s ownership of a federally funded invention is contested — whether by a co-inventor’s prior employer, a sponsor with its own assignment clause, or a visiting researcher’s home institution. It is also a recurring point of confusion worth correcting directly: electing title under Bayh-Dole is not the same event as acquiring title. Election of title is the contractor’s decision, communicated to the funding agency, to retain ownership of an invention it is legally entitled to hold; it presupposes the institution already has (or will obtain) valid assignment from its inventors. See CASRAI’s Bayh-Dole Act dictionary entry for the broader statutory framework, and the 2025 Bayh-Dole march-in proceeding against Harvard for how the government’s retained rights operate once title is settled. For the separate question of who counts as an inventor in the first place, see CASRAI’s guide on authorship vs. patent inventorship and the independent inventor guide on how individual inventors’ rights interact with institutional IP policies.

Frequently asked questions

Does Bayh-Dole give universities automatic ownership of federally funded inventions?

No. Bayh-Dole allows a university (as a federal funding “contractor”) to elect to retain title to an invention it owns, and it sets the compliance and reporting framework that follows from that election. It does not itself transfer inventor ownership to the university; the university must still obtain a valid assignment from the inventor under ordinary patent-assignment law.

What is the difference between “agree to assign” and “hereby assign” language?

“Agree to assign” is a promise to transfer rights in the future and does not itself convey title. “Hereby assign” is a present-tense assignment that transfers the inventor’s interest automatically, without any further instrument, at the moment the invention is conceived. Stanford v. Roche turned on exactly this distinction.

Did Stanford v. Roche change Bayh-Dole itself?

No. The Court interpreted the existing statute; it did not amend or narrow Bayh-Dole’s compliance obligations (disclosure, election of title, march-in rights, and so on). It clarified that those obligations presuppose the contractor already validly holds title through assignment — Bayh-Dole does not supply that title on its own.

What should a TTO check in its own agreements after this case?

Whether the operative assignment clause in employment, student, postdoc, and visiting-researcher agreements uses present-tense “hereby assign” language (rather than only a future promise to assign), and whether that language is captured at the start of the relationship rather than only at the point of invention disclosure.

This page summarizes a Supreme Court decision and general contract-drafting practice for informational purposes. It is not legal advice; institutions should consult university counsel when drafting or revising invention-assignment agreements.

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →